Polymer Factory takes out loan to manage liquidity fluctuations

Polymer Factory Sweden AB (publ) has today decided to take out a loan of SEK 1.0 million from two of its largest shareholders to manage liquidity fluctuations in the short term.

The loan aims to increase the Company's liquidity before the second instalment of the EDF grant is paid, which is expected in early Q4, 2024. The loan has been signed at market terms and runs until November 30, 2024, or earlier if the Company's finances change significantly and the Company finds this advantageous.

For the sake of clarity, the loan is taken up solely in relation to liquidity management and the company's view of the short- and long-term goals is unchanged. Should the Company be unable to fulfill repayment of the loan, the outstanding debt will be converted to shares.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.